Nnrti News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nnrti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nnrti Today - Breaking & Trending Today
1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for treating human immunodeficiency virus (HIV). 2. Dolutegravir treatment for HIV was not associated with an increased risk of adverse events as compared to ritonavir-boosted treatment. Evidence Rating Level: 1 (Excellent) Study Rundown: Currently, the World Health Organization ....
1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for treating human immunodeficiency virus (HIV). 2. Dolutegravir treatment for HIV was not associated with an increased risk of adverse events as compared to ritonavir-boosted treatment. Evidence Rating Level: 1 (Excellent) Study Rundown: Currently, the World ....